ACADIA Pharmaceuticals Inc.
ACADBiotechnology
$20.59−0.82%As of Oct 30vs prior close
- Market cap
- $3.5B
- P/E (TTM)
- 9.2×
- P/E (FY1)
- 34.6×
- From 52W high
- −32.65%
- EPS (LTM)
- $2.23
- Revenue (LTM)
- $1.1B
- Net margin
- 33.42%
- Dividend yield
- 0.00%
Nomior Score
56
Anchored CompounderSpeculativeTop 36% of the scored universe
Growth55
Quality74
Value50
Momentum33
Resilience60
Growth
+58.13%revenue a year over 9 fiscal years
YE16 $17.3MLTM $1.1B
Connections
Revenue to profitQ2 YE26
10% of revenue became net profit.
Who owns it
2funds